These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29162226)

  • 1. Management of Corticosteroid-Induced Osteoporosis: A Practical Approach for the Dermatologist.
    Vico-Alonso C; Maroñas-Jiménez L; Lozano-Morillo F
    Actas Dermosifiliogr (Engl Ed); 2018 May; 109(4):357-358. PubMed ID: 29162226
    [No Abstract]   [Full Text] [Related]  

  • 2. Is the increase in osteoporosis prevention a result of the audit?
    Naunton M
    Clin Neurol Neurosurg; 2006 Oct; 108(7):718-9. PubMed ID: 16621242
    [No Abstract]   [Full Text] [Related]  

  • 3. Corticosteroids: no drug prevention of fractures needed.
    Prescrire Int; 2009 Aug; 18(102):175. PubMed ID: 19746563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and management of osteoporosis in women with breast cancer and men with prostate cancer.
    Hershman D; Narayanan R
    Curr Oncol Rep; 2004 Jul; 6(4):277-84. PubMed ID: 15161581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Severe osteoporosis with vertebral crushes in juvenile dermatomyositis. Effect of oral alendronate therapy].
    Tau C; Russo R
    Medicina (B Aires); 2007; 67(1):53-6. PubMed ID: 17408022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevent corticosteroid-induced osteoporosis.
    Kessenich CR
    Nurse Pract; 2002 Apr; 27(4):15. PubMed ID: 11984415
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of glucocorticoid-induced osteoporosis in immunobullous diseases with alendronate: a randomized, double-blind, placebo-controlled study.
    Tee SI; Yosipovitch G; Chan YC; Chua SH; Koh ET; Chan YH; Tan SS; Tsou IY; Tan SH
    Arch Dermatol; 2012 Mar; 148(3):307-14. PubMed ID: 22105813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiresorptive treatment after proximal femur fracture].
    Muñoz VL; Roger DR; Valle MB; García LL
    Aten Primaria; 2005 Nov; 36(8):467. PubMed ID: 16287563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are oral bisphosphonates effective in improving lumbar bone mineral density in breast cancer survivors with osteopenia or osteoporosis?
    Sawka AM; Ioannidis G; Papaioannou A; Thabane L; Olszynski WP; Brown JP; Hanley DA; Murray TM; Josse RG; Sebaldt RJ; Petrie A; Tenenhouse A; Goldsmith CH; Boulos P; Kouroukis T; Adachi JD
    J Obstet Gynaecol Can; 2005 Aug; 27(8):759-64. PubMed ID: 16287007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination treatment in osteoporosis. Basic treatment plus specific osteoporosis medication].
    Ringe JD
    Med Monatsschr Pharm; 2009 Apr; 32(4):137-40. PubMed ID: 19445270
    [No Abstract]   [Full Text] [Related]  

  • 11. Corticosteroid-induced osteoporosis: a guide to optimum management.
    Cranney A; Adachi JD
    Treat Endocrinol; 2002; 1(5):271-9. PubMed ID: 15832482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.
    Sambrook PN; Kotowicz M; Nash P; Styles CB; Naganathan V; Henderson-Briffa KN; Eisman JA; Nicholson GC
    J Bone Miner Res; 2003 May; 18(5):919-24. PubMed ID: 12733733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and treatment of glucocorticoid-induced osteoporosis in 2005.
    Orcel P
    Joint Bone Spine; 2005 Dec; 72(6):461-5. PubMed ID: 16326129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study.
    Millonig G; Graziadei IW; Eichler D; Pfeiffer KP; Finkenstedt G; Muehllechner P; Koenigsrainer A; Margreiter R; Vogel W
    Liver Transpl; 2005 Aug; 11(8):960-6. PubMed ID: 16035083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus.
    Yeap SS; Fauzi AR; Kong NC; Halim AG; Soehardy Z; Rahimah I; Chow SK; Goh EM
    J Rheumatol; 2008 Dec; 35(12):2344-7. PubMed ID: 19004038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of corticosteroid-induced osteoporosis.
    Stevenson JC
    Lancet; 1998 Oct; 352(9137):1327-8. PubMed ID: 9802265
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiresorptive treatments for corticosteroid-induced osteoporosis: a Bayesian network meta-analysis.
    Migliorini F; Colarossi G; Eschweiler J; Oliva F; Driessen A; Maffulli N
    Br Med Bull; 2022 Sep; 143(1):46-56. PubMed ID: 35641234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplementation of vitamin D plus calcium is effective in corticosteroid-induced osteoporosis management.
    Bijlsma JW
    Clin Exp Rheumatol; 2000; 18(1):3-4. PubMed ID: 10777337
    [No Abstract]   [Full Text] [Related]  

  • 19. How to prevent glucocorticoid-induced osteoporosis.
    Dore RK
    Cleve Clin J Med; 2010 Aug; 77(8):529-36. PubMed ID: 20682515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guidelines for the diagnosis, prevention and treatment of osteoporosis. Italian Osteoporosis, Mineral Metabolism, and Skeletal Diseases Society].
    Società Italiana dell'Osteoporosi, del Metabolismo Minerale e delle Malattie dello Scheletro
    Minerva Endocrinol; 2013 Mar; 38(1 Suppl 1):1-30. PubMed ID: 23539106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.